Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis
Authors:
- G. G. IlleiGIG. G. Illei
- H. A. AustinHAH. A. Austin
- J. F. TisdaleJTJ. F. Tisdale
- T. FleisherTFT. Fleisher
- J. E. BalowJBJ. E. Balow
Open Access
- 27 March 2007
- journal article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 46 (6) , 952-956
Abstract
Objectives. To determine the safety and efficacy of a short course of fludarabine combined with cyclophoshamide in lupus nephritis.Keywords
This publication has 8 references indexed in Scilit:
- Transfusion‐associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosusTransfusion, 2003
- Combination Therapy with Pulse Cyclophosphamide plus Pulse Methylprednisolone Improves Long-Term Renal Outcome without Adding Toxicity in Patients with Lupus NephritisAnnals of Internal Medicine, 2001
- In Vitro Evaluation of Fludarabine in Combination With Cyclophosphamide and/or Mitoxantrone in B-Cell Chronic Lymphocytic LeukemiaBlood, 1999
- Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signalingNature Medicine, 1999
- New York University/Hospital for Joint Diseases experience with intravenous cyclophosphamide treatment: efficacy in steroid unresponsive lupus nephritisLupus, 1995
- Risk for Sustained Amenorrhea in Patients with Systemic Lupus Erythematosus Receiving Intermittent Pulse Cyclophosphamide TherapyAnnals of Internal Medicine, 1993
- The Effect of Cyclophosphamide Pulses on Fertility in Patients With Lupus NephritisAmerican Journal of Reproductive Immunology, 1992
- Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritisThe Lancet, 1992